Neurones (XPAR:NRO) 3-Year Share Buyback Ratio: -0.10% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:NRO Neurones XPAR:NRO
100 GF Score
Price €36.00
GF Value €50.33
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Neurones 3-Year Share Buyback Ratio?

Neurones XPAR:NRO -3.49% 100 3-Year Share Buyback Ratio is -0.10 as of Jun. 2026. GuruFocus rates XPAR:NRO with a GF Score™ of 100/100 and a GF Value™ of €50.33 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 2,132 Software companies, Neurones ranks better than 75.8% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Neurones's current 3-Year Share Buyback Ratio was -0.10%.

The historical rank and industry rank for Neurones's 3-Year Share Buyback Ratio or its related term are showing as below:

XPAR:NRO' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -1   Med: -0.3   Max: 0.4
Current: -0.1

During the past 13 years, Neurones's highest 3-Year Share Buyback Ratio was 0.40%. The lowest was -1.00%. And the median was -0.30%.

XPAR:NRO's 3-Year Share Buyback Ratio is ranked better than
75.8% of 2132 companies
in the Software industry
Industry Median: -1.6 vs XPAR:NRO: -0.10

Neurones (XPAR:NRO) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Neurones 3-Year Share Buyback Ratio Related Terms


XPAR:NRO vs IBM, ACN, CTSH: 3-Year Share Buyback Ratio Comparison

For the Information Technology Services subindustry, Neurones's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurones 3-Year Share Buyback Ratio vs Software Industry

For the Software industry and Technology sector, Neurones's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Neurones's 3-Year Share Buyback Ratio falls into.


XPAR:NRO
100GF Score
Neurones XPAR:NRO
3-Year Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neurones 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 3-Year Share Buyback Ratio of -0.10 mean?
Neurones (XPAR:NRO) has a 3-Year Share Buyback Ratio of -0.10 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Neurones and its competitors. According to the industry distribution chart, Neurones ranks #516 out of 2132 companies in the Software industry, placing it in the top 24.2%.
Is Neurones' 3-Year Share Buyback Ratio too high?
Neurones' current 3-Year Share Buyback Ratio is -0.10. Based on the distribution chart, Neurones ranks #516 out of 2132 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Neurones has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' 3-Year Share Buyback Ratio compare to IBM and ACN?
According to the Software industry distribution chart, Neurones ranks #516 out of 2132 companies for 3-Year Share Buyback Ratio. This places Neurones in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Software company?
A good 3-Year Share Buyback Ratio depends on the Software industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Neurones and its competitors. Neurones's current 3-Year Share Buyback Ratio is -0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Modestly Undervalued. The stock's GF Value™ is €50.33, compared to a current price of €36.00 — trading 28.5% below its estimated fair value. The current 3-Year Share Buyback Ratio is -0.10. Neurones' overall GF Score™ is 100/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current 3-Year Share Buyback Ratio is -0.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neurones (XPAR:NRO) Overvalued in 2026?

Based on GuruFocus' analysis, Neurones stock appears to be undervalued. The current stock price of €36.00 is trading 28.5% below its estimated GF Value™ of €50.33. GuruFocus considers Neurones to be Modestly Undervalued.

Key valuation signals for XPAR:NRO:

  • 3-Year Share Buyback Ratio: -0.10
  • GF Value™: €50.33 vs. price of €36.00 (28.5% below fair value)
  • GF Score™: 100/100 with 3 warning signs

No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Neurones Business Description

Other Exchanges 0GX2:UKNE9:Germany
Address 205 Avenue Georges Clemenceau, Immeuble Le Clemenceau 1 Building, Nanterre, FRA, 92024
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
100GF Score

Get the complete analysis for XPAR:NRO

3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€36.00
Price
€50.33
GF Value